Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.63 - $1.07 $630 - $1,070
-1,000 Reduced 1.08%
91,995 $63,000
Q1 2024

May 14, 2024

BUY
$0.82 - $1.35 $76,255 - $125,543
92,995 New
92,995 $82,000
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $327,197 - $484,982
-83,045 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$4.26 - $6.5 $244,536 - $373,119
-57,403 Reduced 40.87%
83,045 $364,000
Q1 2021

May 12, 2021

SELL
$5.03 - $8.8 $3,707 - $6,485
-737 Reduced 0.52%
140,448 $872,000
Q4 2020

Feb 11, 2021

SELL
$4.04 - $5.31 $13,105 - $17,225
-3,244 Reduced 2.25%
141,185 $690,000
Q3 2020

Nov 16, 2020

BUY
$3.64 - $7.76 $2,642 - $5,633
726 Added 0.51%
144,429 $608,000
Q2 2020

Aug 14, 2020

BUY
$4.78 - $8.26 $377 - $652
79 Added 0.06%
143,703 $994,000
Q1 2020

May 14, 2020

SELL
$4.0 - $21.53 $23,924 - $128,770
-5,981 Reduced 4.0%
143,624 $574,000
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $23,182 - $40,111
1,663 Added 1.12%
149,605 $3.21 Million
Q3 2019

Nov 13, 2019

BUY
$13.89 - $23.16 $131,066 - $218,537
9,436 Added 6.81%
147,942 $2.24 Million
Q2 2019

Aug 13, 2019

BUY
$16.27 - $20.51 $4,620 - $5,824
284 Added 0.21%
138,506 $2.69 Million
Q1 2019

May 13, 2019

SELL
$12.61 - $22.33 $2,698 - $4,778
-214 Reduced 0.15%
138,222 $2.87 Million
Q4 2018

Feb 12, 2019

SELL
$12.41 - $22.98 $69,074 - $127,906
-5,566 Reduced 3.87%
138,436 $1.88 Million
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $75,153 - $499,082
30,675 Added 27.07%
144,002 $2.34 Million
Q2 2018

Sep 18, 2018

SELL
$2.68 - $3.48 $51,469 - $66,833
-19,205 Reduced 14.49%
113,327 $350,000
Q2 2018

Aug 14, 2018

BUY
$2.68 - $3.48 $103,970 - $135,006
38,795 Added 41.39%
132,532 $410,000
Q1 2018

May 09, 2018

SELL
$2.99 - $4.44 $5,980 - $8,880
-2,000 Reduced 2.09%
93,737 $282,000
Q4 2017

Feb 14, 2018

SELL
$3.06 - $4.09 $3,130 - $4,184
-1,023 Reduced 1.06%
95,737 $384,000
Q3 2017

Nov 13, 2017

BUY
$3.03 - $3.72 $293,182 - $359,947
96,760
96,760 $339,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.